Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.35 - $0.53 $1,055 - $1,597
-3,015 Reduced 22.71%
10,262 $5,000
Q3 2023

Nov 14, 2023

BUY
$0.38 - $0.58 $634 - $968
1,670 Added 14.39%
13,277 $5,000
Q2 2023

Aug 09, 2023

SELL
$0.39 - $0.94 $46 - $112
-120 Reduced 1.02%
11,607 $5,000
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $16,535 - $29,317
11,727 New
11,727 $18,000
Q3 2020

Nov 13, 2020

SELL
$9.57 - $27.05 $70,195 - $198,411
-7,335 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$7.14 - $31.69 $52,371 - $232,446
7,335 New
7,335 $198,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $456M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.